Results of the Echelon-1 Trial New chemotherapy is a combination of brentuximab vedotin, and AVD
Joseph M. Connors, MD from British Colombia Cancer Agency discusses results of the Echelon-1 Trial and new chemotherapy that is a combination of brentuximab vedotin, and AVD at the 2017 American Socie...
Author: ASHReport
Added: 01/11/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts